- Antimicrobial thermoplastic polyurethane for tubes and catheters added to HyGentic® range of compounds
- High-performance thermoplastics for injection molding and extrusion

The focus of BASF’s booth at the Compamed tradeshow in Düsseldorf, Germany, is on the latest antimicrobial thermoplastic polyurethane (TPU) products in the HyGentic® product portfolio and a range of high-performance plastics for medical technology. BASF will be exhibiting its solutions from November 20 through 22, 2103 in Booth No. G21, Hall 08B.

HyGentic TPU is an antimicrobial thermoplastic polyurethane dedicated to the production of medical devices that contains integrated silver ions and protects the product surface from contamination by microbes. This TPU is particularly suitable for tubes and catheters in hygiene-sensitive uses.

HyGentic SA is an antimicrobial styrene acrylic copolymer offering similar hardness to polycarbonate. It is transparent, easy to process, and therefore ideal for medical device housings and plug-in connectors in hygiene-sensitive environments.

HyGentic SBC is a transparent antimicrobial injection-moldable styrene butadiene copolymer compound that equally contains antimicrobial silver ions. The ready-to-use compound can be used to manufacture medical devices, such as inhalers or ventilation filters.

HyGentic PA is an antimicrobial glass-fiber-reinforced, injection-moldable polyamide compound that is exceptionally well suited to the production of operating elements for medical devices.

“All HyGentic compounds are extremely effective against a broad variety of bacteria and fungi found in the hospital environment,” explained Edgar Eichholz, Business Development Manager Medical Device Materials, BASF New Business. Medical devices produced from these materials can be disinfected by conventional procedures. “Hospitals can support their hygiene routine by using medical devices manufactured from HyGentic compounds,” Eichholz pointed out.

BASF’s medical devices team has the expertise and facilities it takes to produce customized application-focused formulations and test them for antimicrobial effectiveness, and will incorporate them into materials adjusted for use on the equipment available. A dedicated microbiology team checks the various formulations obtained for antimicrobial effectiveness against relevant microorganisms, including multiresistant pathogens like MRSA (methicillin-resistant Staphylococcus aureus).

“The selective combination of organic and inorganic antimicrobial ingredients produces synergy effects and boosts the efficiency of the individual components,” Eichholz explained. The formulations obtained in this way act faster and remain effective for a longer period.

High-performance thermoplastics in medical technology

BASF’s plastics portfolio identified by the suffix “PRO,” which has been geared specifically to meet the needs of the medical technology industry, comprises two classes of materials: the Ultraform® PRO range (POM: polyoxymethylene; polyacetal) and Ultradur® B4520 PRO (PBT: polybutylene terephthalate).

New Ultraform PRO with optimized sliding friction
The new Ultraform W2320 003 PRO TR (TR: tribology-optimized) is a preferred choice especially when it comes to minimizing friction between two functional elements that come into contact, so as to avoid unwanted noise in application. The material also features excellent flowability. A special lubricant minimizes squeaking and stick-slip.

Comprehensive service package for medical technology
Along with its plastics from the “PRO” family (PRO: profile covered raw materials only) BASF offers a comprehensive service package that has been adapted specifically to the requirements of medical technology. Aside from support relating to applications technology, this package entails the explicit commitment that no changes will be made in the plastic formulation stored in the Drug Master File (DMF) at the FDA. All product grades of the PRO range have been shown to comply with the applicable international standards and tests for medical technology uses of plastics such as the EU, US and Japanese Pharmacopeias and DIN EN ISO 10993-5. Such tests are performed (on pellets) by independent third-party institutes.

Heat-resistant Ultrason®
With its stability at high temperatures and exceptional chemical resistance, Ultrason®, too, is suitable for medical technology applications. What is more: it is transparent. In addition, most products from this range have been certified to the typical food contact and drinking water standards.

About BASF
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF posted sales of €72.1 billion in 2012 and had more than 110,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com

toevoeging XEA.nl
Corbion
Na de verkoop van overbodige last is het bed nu opgemaakt voor een verdere samenwerking met BASF.
Corbion werkt al langer samen, maar nu zullen er spijkers met koppen geslagen gaan worden door Basf. Straks moeten zij tegen meerdere opbieden.

reg AFM
per 13 nov. j.l
heeft Lansdowne Partners International Limited 4,19% belang en 7,32% stemrecht in Corbion.
per 2 nov. heeft Norges Bank 2,12% in Corbion
per 4 nov. heeft Norges Bank 2,44% in Corbion.
per 22 okt j.l. heeft BlackRock, Inc. 3,07% belang en 3,01% stemrecht in Corbion.
Per 14 nov. heeft SusqueHanna 1,88% baisse poisite in Corbion.